Medicare Enrolled
Dr. Robinson Koilpillai, M.D.
Family Medicine · Winter Haven, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Koilpillai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Koilpillai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Koilpillai
Dr. Robinson Koilpillai is a family medicine specialist in Winter Haven, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Koilpillai performed 21,668 Medicare services across 9,729 unique beneficiaries.
Between the years covered by Open Payments, Dr. Koilpillai received a total of $3,114 from 32 pharmaceutical and/or device companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Koilpillai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in FL
$3,114 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 68724 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗21,668
Medicare services
Top 0% in FL for family medicine
9,729
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,083 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 2,950 | $0 | $0 |
| Dexamethasone injection (steroid) | 1,387 | $0 | $0 |
| Blood draw (venipuncture) | 1,339 | $8 | $9 |
| Denosumab injection (Prolia/Xgeva) | 1,260 | $18 | $39 |
| Complete blood count (CBC) with differential | 1,166 | $8 | $16 |
| Comprehensive metabolic blood panel | 989 | $10 | $21 |
| Office visit, established patient (30-39 min) | 850 | $84 | $218 |
| Hemoglobin A1c test (diabetes monitoring) | 820 | $10 | $19 |
| Thyroid stimulating hormone (TSH) test | 682 | $16 | $34 |
| Office visit, established patient (20-29 min) | 609 | $61 | $150 |
| Vitamin D level test | 501 | $29 | $59 |
| Parathyroid hormone level test | 440 | $40 | $83 |
| Phosphate level test | 426 | $5 | $9 |
| Creatinine test (kidney function) | 396 | $5 | $10 |
| Urine microalbumin test (kidney screening) | 388 | $6 | $12 |
| Drug injection, under skin or into muscle | 375 | $10 | $42 |
| Lipid panel (cholesterol and triglycerides) | 357 | $13 | $27 |
| Free thyroxine (T4) test | 357 | $9 | $18 |
| Annual wellness visit, follow-up | 322 | $126 | $231 |
| Annual depression screening | 292 | $18 | $36 |
| Injection, ketorolac tromethamine, per 15 mg | 282 | $0 | $1 |
| Urinalysis using microscope | 265 | $3 | $6 |
| Automated urinalysis | 262 | $2 | $4 |
| Vitamin B-12 level test | 259 | $15 | $30 |
| Urinalysis with microscopic exam | 241 | $3 | $6 |
| Prothrombin time test (blood clotting) | 228 | $4 | $9 |
| Ferritin level test (iron stores) | 211 | $13 | $27 |
| Iron level test | 211 | $6 | $13 |
| Uric acid level test | 209 | $4 | $9 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 209 | $15 | $45 |
| Transferrin (iron binding protein) level | 208 | $12 | $26 |
| Urine culture, bacterial identification | 178 | $8 | $34 |
| Office visit, established patient, complex (40-54 min) | 172 | $126 | $294 |
| Electrocardiogram (EKG), 12-lead | 170 | $10 | $51 |
| Flu vaccine administration | 151 | $18 | $18 |
| Flu vaccine, high-dose | 150 | $72 | $183 |
| Detection test by immunoassay with direct visual observation for influenza virus | 142 | $16 | $33 |
| Chest X-ray, 2 views | 134 | $23 | $96 |
| Pneumonia vaccine administration | 132 | $30 | $56 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 131 | $282 | $530 |
| Magnesium level test | 106 | $7 | $13 |
| Ceftriaxone antibiotic injection | 104 | $0 | $1 |
| Urine culture, bacterial colony count | 98 | $8 | $34 |
| Screening mammography | 95 | $123 | $369 |
| Liver function blood test panel | 95 | $8 | $16 |
| 3D screening mammography (tomosynthesis) | 90 | $51 | $154 |
| Basic metabolic blood panel | 88 | $8 | $17 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 71 | $34 | $90 |
| Administration of vaccine | 68 | $13 | $42 |
| Transitional care management services for problem of high complexity | 63 | $211 | $487 |
| Folic acid level test | 54 | $14 | $29 |
| Bone density scan (DEXA) | 52 | $36 | $116 |
| Natriuretic peptide (heart and blood vessel protein) level | 49 | $38 | $79 |
| Prostate cancer screening; prostate specific antigen test (psa) | 49 | $19 | $39 |
| Sed rate test (inflammation marker) | 45 | $3 | $5 |
| Red blood count, automated test | 42 | $4 | $8 |
| Thyroid hormone, t3 measurement, total | 38 | $14 | $28 |
| X-ray of lower and sacral spine, 2-3 views | 33 | $23 | $112 |
| Troponin (protein) analysis, quantitative | 30 | $12 | $25 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 30 | $45 | $208 |
| Joint injection, major joint | 29 | $50 | $192 |
| PSA test (prostate cancer screening) | 29 | $18 | $37 |
| Hepatitis c antibody measurement | 26 | $14 | $29 |
| Knee X-ray, 3 views | 21 | $31 | $115 |
| Injection, methylprednisolone acetate, 80 mg | 21 | $8 | $24 |
| CT scan of chest, without contrast | 20 | $92 | $465 |
| X-ray of knee, 1-2 views | 20 | $21 | $98 |
| Low dose ct scan of chest for lung cancer screening | 19 | $134 | $406 |
| Blood creatinine level | 19 | $5 | $10 |
| CT scan of abdomen and pelvis with contrast | 18 | $242 | $959 |
| Urea nitrogen level to assess kidney function, quantitative | 18 | $4 | $8 |
| Shoulder X-ray, 2+ views | 17 | $23 | $97 |
| CT scan of head/brain, without contrast | 16 | $77 | $341 |
| Ct scan of abdomen and pelvis without contrast | 16 | $146 | $592 |
| Complete ultrasound scan behind abdominal cavity | 15 | $73 | $333 |
| Total protein level, urine | 15 | $4 | $7 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $49 | $150 |
| Transitional care management services for problem of at least moderate complexity | 15 | $141 | $368 |
| Analysis for antibody to campylobacter (intestinal bacteria) | 13 | $13 | $26 |
| Stool culture | 13 | $9 | $19 |
| Detection test by immunoassay technique for cryptosporidium (parasite) | 13 | $14 | $28 |
| Detection test by immunoassay technique for giardia (intestinal parasite) | 13 | $12 | $24 |
| Ultrasound scan of head and neck soft tissue | 12 | $78 | $340 |
| Urinalysis, manual | 12 | $3 | $7 |
| Coagulation assessment blood test, plasma or whole blood | 12 | $6 | $12 |
| Detection test by immunoassay technique for shiga-like toxin (bacterial toxin) | 12 | $12 | $24 |
| Detection test by immunoassay technique for other organism | 12 | $12 | $24 |
| Detection test by immunoassay with direct visual observation for clostridium difficile toxin a | 12 | $16 | $32 |
| Ct scan of chest with contrast | 11 | $115 | $576 |
| Hip X-ray, 2-3 views | 11 | $26 | $132 |
| Ultrasound of both sides of head and neck blood flow | 11 | $146 | $586 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $148 | $333 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
30.2% medium
69.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,114
Total received (2018-2024)
Avg $445/year across 7 years
Top 16% in FL for family medicine
32
Companies
171
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,114 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$548
2023
$517
2022
$489
2021
$703
2020
$575
2019
$268
2018
$15
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$474
Boehringer Ingelheim Pharmaceuticals, Inc.
$451
Amgen Inc.
$270
ABBVIE INC.
$230
PFIZER INC.
$221
Novo Nordisk Inc
$218
AbbVie Inc.
$161
GlaxoSmithKline, LLC.
$145
Bayer Healthcare Pharmaceuticals Inc.
$98
Abbott Laboratories
$82
Daiichi Sankyo Inc.
$73
Biohaven Pharmaceuticals, Inc.
$73
Lilly USA, LLC
$71
Biohaven Pharmaceutical Holding Company Ltd.
$66
Novartis Pharmaceuticals Corporation
$57
Bayer HealthCare Pharmaceuticals Inc.
$54
Eisai Inc.
$51
Allergan, Inc.
$48
Kowa Pharmaceuticals America, Inc.
$37
Merck Sharp & Dohme LLC
$24
Amarin Pharma Inc.
$23
Biogen, Inc.
$22
Dexcom, Inc.
$20
Merck Sharp & Dohme Corporation
$19
Otsuka America Pharmaceutical, Inc.
$17
Janssen Pharmaceuticals, Inc
$17
Teva Pharmaceuticals USA, Inc.
$16
SANOFI-AVENTIS U.S. LLC
$16
Genentech USA, Inc.
$15
Lundbeck LLC
$14
Antares Pharma, Inc.
$14
Tolmar, Inc.
$14
Top 3 companies account for 38.4% of total payments
Associated products mentioned in payments ›
ADUHELM · AIRSUPRA · AJOVY · AREXVY · Aimovig · BASAGLAR · BREZTRI · CHANTIX · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE · GARDASIL · INJECTAFER · INVOKANA · JARDIANCE · JATENZO · Kerendia · LEQVIO · Livalo · MULTAQ · NOCDURNA · NURTEC ODT · Otezla · Ozempic · PNEUMOVAX 23 · PREVNAR 13 · PREVNAR 20 · QULIPTA · REXULTI · Repatha · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VRAYLAR · VYEPTI · VYNDAMAX · Vascepa · Victoza · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $14 per 100 Medicare services performed
Geographic Context
Family medicine physicians within 10 mi
236
Per 100K population
31.0
County median income
$63,644
Nearest hospital
WINTER HAVEN HOSPITAL
6.0 mi
6.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Koilpillai is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with low-engagement industry engagement in the top 16% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Koilpillai experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Koilpillai performed 2,950 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Koilpillai receive payments from pharmaceutical companies?
Yes. Dr. Koilpillai received a total of $3,114 from 32 companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Koilpillai's costs compare to other family medicine physicians in Winter Haven?
Dr. Koilpillai's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Koilpillai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Winter Haven
Browse family medicine physicians in Winter Haven ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in FL
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in FL
Which FL family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology